ALDOCK Company
ALDOCK is a company that develops risk tests for the early detection of cancer. They use machine learning to analyze biomarker measurement results and improve inspection accuracy. They also offer a secure API/SDK that can be shared with other applications. The company has 2 employees and is led by the Founder, Chief Executive Officer & President.
Founded Date:
2016-12-01
Last Funding Type:
Seed
Headquarters:
Shinjuku, Yamanashi, Japan
Technology:
Biomarkers
Industry:
Biotechnology, Health Care, Life Science, Product Research
Last Funding Date:
43313
Funding Status:
Seed
Investor Type:
For Profit
Total Funding:
80000000